CK Life Sciences International (Holdings) Inc. (Chinese: ????????????) (SEHK: 775), or CK Life Sciences, is the subsidiary of Cheung Kong Holdings in Hong Kong. It is engaged in the business of research and development, commercialization, marketing and sale of biotechnology products. The chairman is Mr. Victor Li, the elder son of Mr. Li Ka-shing, the chairman of Cheung Kong Holdings. It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002 (Former stock code: SEHK: 8222). It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.